ArticleInvestigative ophthalmology & visual science2026
CGRP/TSP1 Signaling Dampens Corneal Inflammation and Fibrosis by Targeting A2M During Corneal Stromal Wound Healing.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the specific role of thrombospondin-1 (TSP1), encoded by the Thbs1 gene, in corneal stromal wound healing and to elucidate its underlying mechanism. Methods: A corneal stromal injury model was established by removing the epithelium and superficial stroma. We assessed Thbs1 expression using single-cell sequencing and compared the corneal healing responses between wild-type and Thbs1-deficient (Thbs1-/-) mice. Bulk RNA sequencing was conducted to identify key downstream targets of Thbs1. The regulation of TSP1 by calcitonin gene-related peptide (CGRP) was investigated through intervening CGRP signaling in human telomerase-immortalized keratocytes and murine corneas. Results: Thbs1 was highly expressed in corneal stroma and upregulated following injury. Thbs1-/- mice exhibited more severe corneal lesions than wild-type controls, with elevated corneal opacity scores and augmented inflammation and fibrosis markers. Transcriptomic analysis identified A2m (encoding α2-macroglobulin [A2M]) as a key downstream target of Thbs1. A2m expression also increased after injury, peaking later than Thbs1. Topical depletion of A2m in wild-type mice recapitulated the exacerbated corneal phenotype observed in Thbs1-/- mice. Exogenous CGRP robustly induced both TSP1 and A2M expression in vitro and in vivo, but the CGRP receptor antagonist BIBN4096 suppressed their expression and concurrently exacerbated corneal lesions. TSP1 and A2M were similarly upregulated in patients with corneal scarring from alkali burn or fungal infection. Conclusions: Our findings indicate that TSP1 and A2M induction represents a conserved stress-protective response to corneal stromal injury. The CGRP/TSP1/A2M signaling axis is critical for modulating stromal inflammation and fibrosis, highlighting its therapeutic potential for enhancing corneal stromal repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.